Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptability of F/TAF vs F/TDF for HIV Prevention in AGYW
NCT05458765Phase 2Completed
- Sponsor
- Eastern Virginia Medical School
- Start
- Jun 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by Eastern Virginia Medical School. Started Jun 2022; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05458765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05458765.